Tallman MS - Search Results

1

Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response.

Amatangelo MD, Quek L, Shih A, Stein EM, Roshal M, David MD, Marteyn B, Farnoud NR, de Botton S, Bernard OA, Wu B, Yen KE, Tallman MS, Papaemmanuil E, Penard-Lacronique V, Thakurta A, Vyas P, Levine RL. Amatangelo MD, et al. Among authors: tallman ms. Blood. 2017 Aug 10;130(6):732-741. doi: 10.1182/blood-2017-04-779447. Epub 2017 Jun 6. Blood. 2017. PMID: 28588019 Free PMC article. Clinical Trial.

2

Detection of differentiation in acute promyelocytic leukemia.

Tallman MS, Kwaan HC, Weitzman SA. Tallman MS, et al. Blood. 1991 Oct 1;78(7):1892-3. Blood. 1991. PMID: 1912572 Free article. No abstract available.

3

Acute promyelocytic leukemia: a paradigm for differentiation therapy with retinoic acid.

Tallman MS, Rowe JM. Tallman MS, et al. Blood Rev. 1994 Jun;8(2):70-8. doi: 10.1016/s0268-960x(05)80010-4. Blood Rev. 1994. PMID: 7950477 Review. No abstract available.

4

Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study.

Gallagher RE, Willman CL, Slack JL, Andersen JW, Li YP, Viswanatha D, Bloomfield CD, Appelbaum FR, Schiffer CA, Tallman MS, Wiernik PH. Gallagher RE, et al. Among authors: tallman ms. Blood. 1997 Aug 15;90(4):1656-63. Blood. 1997. PMID: 9269786 Free article. Clinical Trial.

5

Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy.

Ding W, Li YP, Nobile LM, Grills G, Carrera I, Paietta E, Tallman MS, Wiernik PH, Gallagher RE. Ding W, et al. Among authors: tallman ms. Blood. 1998 Aug 15;92(4):1172-83. Blood. 1998. PMID: 9694705 Free article. Clinical Trial.

6

Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome.

Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Rowe JM, François C, Larson RS, Wiernik PH. Tallman MS, et al. Blood. 2000 Jan 1;95(1):90-5. Blood. 2000. PMID: 10607690 Free article. Clinical Trial.

7

Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia. Eastern Cooperative Oncology Group.

Lee S, Tallman MS, Oken MM, Cassileth PA, Bennett JM, Wiernik PH, Rowe JM. Lee S, et al. Among authors: tallman ms. Leukemia. 2000 Aug;14(8):1345-8. doi: 10.1038/sj.leu.2401853. Leukemia. 2000. PMID: 10942227

8

Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission.

Tallman MS, Rowlings PA, Milone G, Zhang MJ, Perez WS, Weisdorf D, Keating A, Gale RP, Geller RB, Laughlin MJ, Lazarus HM, Luger SM, McCarthy PL, Rowe JM, Saez RA, Vowels MR, Horowitz MM. Tallman MS, et al. Blood. 2000 Aug 15;96(4):1254-8. Blood. 2000. PMID: 10942365 Free article.

9

Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignancies.

Tallman MS. Tallman MS. Blood Rev. 2001 Sep;15(3):133-42. doi: 10.1054/blre.2001.0160. Blood Rev. 2001. PMID: 11735161 Review. No abstract available.

10

Acute promyelocytic leukemia: evolving therapeutic strategies.

Tallman MS, Nabhan C, Feusner JH, Rowe JM. Tallman MS, et al. Blood. 2002 Feb 1;99(3):759-67. doi: 10.1182/blood.v99.3.759. Blood. 2002. PMID: 11806975 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

673 results

Search Page

Filters